BioAlliance Pharma SA, of Paris, announced that Loramyc was launched simultaneously on the British, German and Danish markets.(Other News To Note)

BioAlliance Pharma SA, of Paris, announced that Loramyc was launched simultaneously on the British, German and Danish markets. Loramyc is its 50-mg, once-a-day topical formulation of miconazole for oropharyngeal candidiasis in immunodepressed patients. It was launched in France last September, and BioAlliance said "prescriptions in France were 35 percent up at the end of March, relative to the end of December 2007, and June's rate was 60 percent above the …